DCN

  • Member Pegasus Capital
  • Sector Life Sciences
  • Date completed 30.11.2020
  • Client DCN Diagnostics, Inc.
  • Country United States
  • Investor Martis Capital
  • Country United States

Pegasus Capital was appointed by the board of DCN Dx to source growth capital to fund the continued expansion of the business.  This process cumulated in Martis Capital, a San Francisco, CA, healthcare-focused private equity firm taking a major stake in the business.

Pegasus Capital
Invested By

Get Started

Find out how the Globalscope family can help you realise your business dreams.

Get In Touch